Fruzaqla 5 mg, Hartkapseln

7680695240023 CH-69524 Kapseln
Fruzaqla 5 mg, Hartkapseln
Fruzaqla 5 mg, Hartkapseln
Fruzaqla 5 mg, Hartkapseln
1 / 3
google

Article details

Package size
21
Selling units
21
Measure
Kapsel(n)
Galenic form
Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
09/09/2024
Patient information leaflet
Français
09/09/2024
Patient information leaflet
Italien
09/09/2024
Summary of Product Characteristics
Allemand
09/09/2024
Summary of Product Characteristics
Français
09/09/2024
Summary of Product Characteristics
Italien
09/09/2024

Detailed composition

Substance Quantity Type Category
(N/A)
5.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FIMDK
(N/A)
0.1829 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK

Reimbursement information

Public price
CHF 4130.55
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/01/2025

Authorization holder

Takeda Pharma AG

8152 Opfikon

Authorization information

Swissmedic authorization number
69524
Drug name
Fruzaqla, Hartkapseln
Galenic form
KAHA
ATC Code
L01EK04
Authorization status
Z
Dispensing category
A
First authorization
27/08/2024
Authorization expiration date
26/08/2029
IT Number
07.16.1.
Domain
Human medicine
Field of application
Erwachsene Patienten mit mCRC

Package details

Description (FR)
FRUZAQLA caps 5 mg bte 21 pce
Description (DE)
FRUZAQLA Kaps 5 mg Ds 21 Stk
Market launch
27/08/2024
Narcotic (BTM)
No

Other package sizes (1)

FRUZAQLA caps 1 mg bte 21 pce
21 KAP
GTIN: 7680695240016
View